Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Genes, Chromosomes & Cancer|July 29, 2015
Identification of somatic gene mutations in penile squamous cell carcinomaCarla Ferrándiz-Pulido, Javier Hernández-Losa, Emili Masferrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on SarcomaRegina Alemany, David S Moura, Andres Redondo, et al.
Pharmaceutics|January 8, 2025
Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 18, 2020
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)Isabelle Ray-Coquard, Helen Hatcher, Emmanuelle Bompas, et al.
British Journal of Cancer|August 30, 2017
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinibHeikki Joensuu, Jean-Yves Blay, Alessandro Comandone, et al.
Oncogene|October 8, 2021
E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumorAlfonso García-Valverde, Jordi Rosell, Sergi Sayols, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse ModelsSara Ortega-Bertran, Juana Fernández-Rodríguez, Miriam Magallón-Lorenz, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Annals of Surgical Oncology|January 23, 2015
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)Jordi Rubió-Casadevall, Javier Martinez-Trufero, Xabier Garcia-Albeniz, et al.
Nature Communications|October 21, 2022
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumorsJavier Martin-Broto, Andres Redondo, David S Moura, et al.
Pageof 7